Patents Assigned to HIV Diagnostics, Inc.
  • Publication number: 20140275139
    Abstract: Multidrug resistance reversers of the d-tetrandrine family are used concurrently with protease inhibitors to treat HIV/AIDS.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: HIV Diagnostics, Inc.
    Inventor: Knox Van Dyke
  • Patent number: 6514955
    Abstract: Disclosed are methods for repressing reproduction of latent viruses, such as HIV, in animals by the generally concurrent administration of (1) antioxidants including a glutathione agent; and (2) an NFKB induction inhibitor. Also disclosed are pharmaceutical compositions and kits for use in repressing reproduction of latent viruses such as HIV.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 4, 2003
    Assignee: HIV Diagnostics, Inc.
    Inventor: Knox Van Dyke
  • Patent number: 5846961
    Abstract: Disclosed are methods for repressing reproduction of latent viruses, such as HIV, in animals by the generally concurrent administration of (1) antioxidants including a glutathione agent; and (2) an NFKB induction inhibitor. Also disclosed are pharmaceutical compositions and kits for use in repressing reproduction of latent viruses such as HIV.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 8, 1998
    Assignee: HIV Diagnostics, Inc.
    Inventor: Knox Van Dyke
  • Patent number: 5686436
    Abstract: Disclosed are methods for repressing reproduction of latent viruses, such as HIV, in animals by the generally concurrent administration of (1) antioxidants including a glutathione agent; and (2) an NFKB induction inhibitor. Also disclosed are pharmaceutical compositions and kits for use in repressing reproduction of latent viruses such as HIV.
    Type: Grant
    Filed: October 4, 1994
    Date of Patent: November 11, 1997
    Assignee: HIV Diagnostics, Inc.
    Inventor: Knox Van Dyke